Cargando…

Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis

Detalles Bibliográficos
Autores principales:	Rivera, Gildardo, Patel, Navin B., Bandyopadhyay, Debasish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530326/ https://www.ncbi.nlm.nih.gov/pubmed/34692649 http://dx.doi.org/10.3389/fchem.2021.775327

Ejemplares similares

An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases
por: J, Brindha, et al.
Publicado: (2021)

Parasite Prolyl Oligopeptidases and the Challenge of Designing Chemotherapeuticals for Chagas Disease, Leishmaniasis and African Trypanosomiasis
por: Bastos, I.M.D, et al.
Publicado: (2013)

Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
por: Nagle, Advait S., et al.
Publicado: (2014)

Editorial: Cheminformatics Approaches in Drug Discovery for Neglected Tropical Diseases
por: Scotti, Luciana, et al.
Publicado: (2021)

Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease
por: Lenk, Edeltraud J., et al.
Publicado: (2018)

Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
por: Scariot, Debora B., et al.
Publicado: (2022)

Editorial: Ethnopharmacological Strategies for Drug Discovery Against African Neglected Diseases
por: Igoli, John O., et al.
Publicado: (2022)

Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease
por: Roquero, Irene, et al.
Publicado: (2019)

Historical aspects of American trypanosomiasis (Chagas' disease)
por: Cueto, Marcos
Publicado: (1998)

Neglected Diseases in the News: A Content Analysis of Recent International Media Coverage Focussing on Leishmaniasis and Trypanosomiasis
por: Balasegaram, Mangai, et al.
Publicado: (2008)

An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases
por: Kourbeli, Violeta, et al.
Publicado: (2021)

The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases
por: Simarro, Pere P, et al.
Publicado: (2010)

Management of trypanosomiasis and leishmaniasis
por: Barrett, Michael P., et al.
Publicado: (2012)

Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis
por: Thomas, Sarah M., et al.
Publicado: (2016)

Phenotypic Drug Discovery for Human African Trypanosomiasis: A Powerful Approach
por: Buckner, Frederick S., et al.
Publicado: (2020)

Benzopyrazine-Based Small Molecule Inhibitors As Trypanocidal and Leishmanicidal Agents: Green Synthesis, In Vitro, and In Silico Evaluations
por: Rock, Jonathan, et al.
Publicado: (2021)

Use of Artificial Intelligence and Machine Learning for Discovery of Drugs for Neglected Tropical Diseases
por: Winkler, David A.
Publicado: (2021)

Erratum: Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis
por: Thomas, Sarah M., et al.
Publicado: (2017)

Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug Discovery
por: Singh, Baljinder, et al.
Publicado: (2023)

Compounds from African Medicinal Plants with Activities Against Selected Parasitic Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis
por: Simoben, Conrad V., et al.
Publicado: (2018)

African trypanosomiasis
por: Morrison, L J, et al.
Publicado: (2011)

Editorial: Current approaches in infectious disease drug discovery
por: Silva-Jr, Floriano P., et al.
Publicado: (2022)

A Literature Review of Economic Evaluations for a Neglected Tropical Disease: Human African Trypanosomiasis (“Sleeping Sickness”)
por: Sutherland, C. Simone, et al.
Publicado: (2015)

Discovery of Infection Associated Metabolic Markers in Human African Trypanosomiasis
por: Lamour, Sabrina D., et al.
Publicado: (2015)

Chagas Disease Drug Discovery in Latin America—A Mini Review of Antiparasitic Agents Explored Between 2010 and 2021
por: de Oliveira, Ramon G., et al.
Publicado: (2021)

An approach to the development of new drugs for African trypanosomiasis
Publicado: (1978)

Chagas Disease and the London Declaration on Neglected Tropical Diseases
por: Tarleton, Rick L., et al.
Publicado: (2014)

American trypanosomiasis, or Chagas disease, in Panama: a chronological synopsis of ecological and epidemiological research
por: Rodriguez, Indra G., et al.
Publicado: (2017)

Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter
por: GILBERT, IAN H.
Publicado: (2014)

Trypanosoma brucei Interaction with Host: Mechanism of VSG Release as Target for Drug Discovery for African Trypanosomiasis
por: Moreno, Cláudia Jassica Gonçalves, et al.
Publicado: (2019)

The history of African trypanosomiasis
por: Steverding, Dietmar
Publicado: (2008)

Advances in preclinical approaches to Chagas disease drug discovery
por: Villalta, Fernando, et al.
Publicado: (2019)

Psychosocial burden of neglected tropical diseases in eastern Colombia: an explorative qualitative study in persons affected by leprosy, cutaneous leishmaniasis and Chagas disease
por: van Wijk, Robin, et al.
Publicado: (2021)

African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase
por: West, Ryan A., et al.
Publicado: (2017)

Chagas disease (American trypanosomiasis) in the context of the 2030 agenda. Insights into global warming and vector control
por: Jurberg, José
Publicado: (2022)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
por: Khare, Shilpi, et al.
Publicado: (2016)

Neglected Parasitic Infections in the United States: Chagas Disease
por: Montgomery, Susan P., et al.
Publicado: (2014)

Scrutinizing the Biomarkers for the Neglected Chagas Disease: How Remarkable!
por: Pinho, Rosa T., et al.
Publicado: (2016)

Editorial: Chagas disease novel drug targets and treatments
por: Duschak, Vilma G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lt39f8i8bgp9du5lbaa7id9812